Skip to main content

Nilutamide

ADVERTISEMENT
Identification
Molecular formula
C12H11F3N2O4
CAS number
63612-50-0
IUPAC name
N-(2-aminoethyl)-2-[4-[[2-[4-[[9-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]phenyl]acetyl]amino]phenyl]acetamide
State
State

Nilutamide is typically a solid at room temperature.

Melting point (Celsius)
197.00
Melting point (Kelvin)
470.00
Boiling point (Celsius)
300.00
Boiling point (Kelvin)
573.00
General information
Molecular weight
317.34g/mol
Molar mass
317.3390g/mol
Density
1.4550g/cm3
Appearence

Nilutamide typically appears as a white to off-white, crystalline powder. It is not very soluble in water, but it is soluble in organic solvents like ethanol, acetone, and chloroform.

Comment on solubility

Solubility of N-(2-aminoethyl)-2-[4-[[2-[4-[[9-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]phenyl]acetyl]amino]phenyl]acetamide

The solubility of the compound N-(2-aminoethyl)-2-[4-[[2-[4-[[9-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]phenyl]acetyl]amino]phenyl]acetamide with the formula C12H11F3N2O4 can be complex and is influenced by various factors.

Key points regarding its solubility include:

  • Polarity: This compound contains multiple functional groups, including amine and hydroxyl groups, which typically enhance solubility in polar solvents.
  • Hydrogen Bonding: The presence of hydroxyl (-OH) groups suggests the ability to engage in hydrogen bonding, potentially increasing solubility in water and other polar solvents.
  • Temperature Sensitivity: Solubility may vary with temperature; higher temperatures often increase solubility for many organic compounds.
  • pH Dependency: The functional groups can also affect solubility based on the pH of the solution, influencing the ionization state of the molecule.

In conclusion, while this compound is expected to have reasonable solubility in polar solvents, specific solubility data would require experimental determination for precise applications and formulations. Always refer to empirical data when working with chemical substances to understand their behavior in different environments.

Interesting facts

Interesting Facts about N-(2-aminoethyl)-2-[4-[[2-[4-[[9-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]phenyl]acetyl]amino]phenyl]acetamide

This compound is a fascinating example of a complex organic molecule that has garnered attention due to its potential applications in pharmaceuticals. Here are some intriguing points about this compound:

  • Pharmaceutical Potential: The intricate structure of this compound suggests it may play a role in drug development, particularly in the treatment of diseases where purine metabolic pathways are involved.
  • Structural Complexity: With various functional groups like amines and hydroxyls, the compound exhibits characteristics that allow for specific interactions with biological targets, making it a subject of interest for medicinal chemistry.
  • Biological Activities: Compounds of this nature often possess various biological activities, which could include anti-inflammatory, anti-cancer, or antiviral effects. Research is ongoing to elucidate these potential applications.
  • Synthesis Challenges: The synthesis of such a complex molecule often comes with challenges, requiring advanced techniques in organic chemistry to achieve the desired configuration and purity.
  • Research Insights: As a multi-functional compound, it presents opportunities for research into structure-activity relationships, an essential aspect of drug design.

In summary, N-(2-aminoethyl)-2-[4-[[2-[4-[[9-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]phenyl]acetyl]amino]phenyl]acetamide is more than just a chemical entity; it represents the intersection of biology, chemistry, and the potential for innovation in therapeutic interventions. Its classification and subsequent exploration can yield insights into how we can manipulate chemical properties for beneficial outcomes.

Synonyms
Adenosine amine congener
ADAC
6-ADAC;ADAC agonist
BCP31853
AKOS040759227
N-(2-aminoethyl)-2-[4-[[2-[4-[[9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]phenyl]acetyl]amino]phenyl]acetamide
N-(2-aminoethyl)-2-(4-{2-[4-({9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl}amino)phenyl]acetamido}phenyl)acetamide